Table 2.

Sample baseline information: comparison of general data, disease history, and medication history of control group, familial hypertension group, and familial hypertension combined with hyperlipidemia group.

Baseline indicator		Control group	Familial hypertension	Familial hypertension combined with hyperlipemia	P
Natural properties	Number of cases (n)	22	25	19
	Gender distribution (female cases/proportion (%))	6 (27.27)	8 (32)	6 (31.58)	0.930
	Age (years)	53.55 ± 15.02	52.92 ± 29.91	52.32 ± 21.12	0.701
	Smoking history (positive cases/proportion (%))	8 (36.36)	7 (28)	8 (42.10)	0.613
Disease history	Diabetes mellitus	10 (45.45)	12 (48)	9 (47.37)	0.984
	Type I diabetes mellitus	1 (4.54)	0 (0)	1 (5.26)	0.528
	Type II diabetes mellitus	9 (40.9)	12 (48)	7 (36.84)	0.748
	Hyperlipidemia	0 (0)	0 (0)	19 (100)	<0.001
	Atherosclerosis	19 (86.36)	22 (88)	16 (84.21)	0.936
	Heart failure	1 (4.54)	0 (0)	1 (5.26)	0.528
	Angina	2 (9.09)	2 (8)	2 (10.53)	0.959
	Stable	0 (0)	1 (4)	0 (0)	0.435
	Unstable	2 (9.09)	1 (4)	2 (10.53)	0.682
	Myocardial infarction	10 (45.45)	11 (44)	10 (52.63)	0.838
	STEMI	5 (22.73)	4 (16)	7 (36.84)	0.273
	NSTEMI	5 (22.73)	7 (28)	5 (26.32)	0.916
	Stroke	0 (0)	0 (0)	0 (0)	1.000
Drug use history	Aspirin	12 (54.54)	10 (40)	10 (52.63)	0.556
	Clopidogrel	10 (45.45)	10 (40)	9 (47.37)	0.874
	Insulin	10 (45.45)	11 (44)	9 (47.37)	0.976
	OHA	12 (54.54)	10 (40)	9 (47.37)	0.608
	Statins	0 (0)	0 (0)	19 (100)	<0.001
	β-Receptor blocking pharmacon	2 (9.09)	22 (88)	19 (100)	<0.001
	Diuretic	3 (13.64)	23 (92)	18 (94.7)	<0.001
	CCB	0 (0)	21 (84)	19 (100)	<0.001
	ACEI	2 (9.09)	20 (80	18 (94.7)	<0.001
	ARB	1 (4.54)	22 (88)	19 (100)	<0.001
Blood pressure level	Systolic pressure (mmHg)	129.82 ± 35.58	149.24 ± 94.023	155.42 ± 56.04	<0.001